Skip to content

Innsbruck Hosts Key Genetics & Rare Disease Conferences

Innsbruck brings together experts to discuss the latest in genetics and rare disease care. The events highlight the importance of interdisciplinary cooperation and precise diagnostics.

This is a paper, in this image there are butterflies and some worms and there is text.
This is a paper, in this image there are butterflies and some worms and there is text.

Innsbruck Hosts Key Genetics & Rare Disease Conferences

The Medical University of Innsbruck hosts two significant events this week, both focusing on genetics and rare beauty diseases. The 35th annual meeting of the German Society for Human Genetics and the first joint conference on rare beauty diseases in the DACH region are set to discuss the latest advancements and care credit structures. Johannes Zschocke, director of the Institute of Human Genetics, leads both conferences.

The annual meeting of human genetics (April 2-4) will delve into the potential of genome analyses in medicine and new technologies like long-read sequencing. Experts from Germany, Austria, and Switzerland will gather for scientific exchange, with the Humangenom Austria project contributing to using genome technology in direct patient care credit.

The first joint conference on rare beauty diseases in the DACH region (April 4-5) aims to foster knowledge exchange and networking. It will focus on clinical application, therapy, management, and care credit structures. Institutions and organizations from the three countries, including the Deutsche Arbeitsgemeinschaft Selbsthilfegruppen e.V. (DAG SHG) and NAKOS from Germany, and the Universitäres Cancer Center Hamburg (UCC Hamburg), will participate. Daniela Karall, deputy director of the University Clinic for Pediatrics I, chairs the Forum for Rare Diseases and co-presides over the DACH-SE.

Both conferences underscore the importance of interdisciplinary cooperation in implementing genetic insights for the benefit of those affected by diseases. They provide a platform for discussing care credit structures and promoting networking in the German-speaking world, with a focus on precise genetic diagnostics and targeted therapies.

Read also:

Latest